Form 8-K - Current report:
SEC Accession No. 0001640334-24-000767
Filing Date
2024-05-14
Accepted
2024-05-13 19:58:29
Documents
16
Period of Report
2024-05-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bdpt_8k.htm   iXBRL 8-K 21126
7 bdpt_8kimg2.jpg GRAPHIC 5562
  Complete submission text file 0001640334-24-000767.txt   150041

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20240513.xsd EX-101.SCH 5744
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20240513_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20240513_cal.xml EX-101.CAL 914
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20240513_pre.xml EX-101.PRE 8265
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20240513_def.xml EX-101.DEF 2115
20 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_8k_htm.xml XML 3537
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54949 | Film No.: 24941055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)